Effectiveness of Kaltenborn End Range Joint Mobilization Technique and Post FacilitationStretch in Shoulder Impingement Syndrome

May 22, 2023 updated by: Neuro Counsel Hospital, Pakistan

Effectiveness of Kaltenborn End Range Joint Mobilization Technique and Post Facilitation Stretch in Shoulder Impingement Syndrome

This study is a experimental one to observe the efficacy of joint mobilization and post facilitation techniques in shoulder impingement syndrome

Study Overview

Detailed Description

his study is a experimental one to observe the efficacy of Kalternborn end range joint mobilization and post facilitation techniques in shoulder impingement syndrome. Goniometer, shoulder disability index will be the tool used for evaluation

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal
      • Islamabad, Federal, Pakistan, 44000
        • Al Nafees Medical Hospital, Islamabd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Both male and female
  • Age 25 to 45
  • Diagnosed Rotator cuff impingement from ortho, neuro and musculoskeletal department
  • Hawkin kennedy test positive
  • Neer's test positive
  • Jobe's test positive

Exclusion Criteria:

  • Cervical spine disorder
  • Fractures
  • Major upper limb surgery
  • Tumor or wound
  • Diagnosed acromial malformations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control group
kalternborn joint mobilization techniques will be administered for total of 8 weeks at the rate of 2 session per week.
This is a join mobilization technique to reduce the joint stiffness and help in improving joint range of motion
Experimental: experimental group
Post stretch facilitation technique will be administered for total of 8 weeks at the rate of 2 session per week.
This is a PNF techniques used to relax the muscles and help in getting more free range of restricted joint

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometer
Time Frame: 4 weeks
This is a instrument designed to evaluate the joint range of motion. Greater ranges mean more mobility of joint and less means more restriction
4 weeks
Shoulder Pain and Disability Index
Time Frame: 4 weeks
Used to assess the patients level of pain and the ADLs which are affected. O score means no dysfuction of joint and higer score means more dysfuction
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2023

Primary Completion (Actual)

May 4, 2023

Study Completion (Actual)

May 4, 2023

Study Registration Dates

First Submitted

May 13, 2023

First Submitted That Met QC Criteria

May 22, 2023

First Posted (Actual)

May 23, 2023

Study Record Updates

Last Update Posted (Actual)

May 23, 2023

Last Update Submitted That Met QC Criteria

May 22, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Have not decided yet about this.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Impingement Syndrome

Clinical Trials on KAlternborn Joint Mobilization

Subscribe